HIV Treatment Access and Scale-Up for Delivery for IDU in Ukraine with Opiate Substitution Therapy with Buprenorphine - Programme Description and Policy Implications

摘要

BackgroundInjection drug use (IDU) accounts for 70% of HIV cases in Ukraine. Until buprenorphine maintenance therapy (BMT) was introduced, few effective strategies aimed at achieving reduction in illicit drug use were available as a conduit to antiretroviral therapy (ARV) among IDUs.